Gestational Trophoblastic Neoplasia clinical trials

Explore recruiting gestational trophoblastic neoplasia clinical trials.

Recruiting gestational trophoblastic neoplasia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gestational Trophoblastic Neoplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TROPHAMET, a phase I/II trial of Avelumab and METhotrexate in low-risk gestational TROPHoblastic neoplasias as first line treatment

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Gestational Trophoblastic Neoplasia trials by city

Gestational Trophoblastic Neoplasia clinical trials

Recruiting gestational trophoblastic neoplasia studies right now

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment

Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Also recruiting in Europe

TROPHAMET, a phase I/II trial of Avelumab and METhotrexate in low-risk gestational TROPHoblastic neoplasias as first line treatment

Gestational Trophoblastic Neoplasia trials by city

Other conditions